Capital Flow Monitor · Sponsors · CIK 2156252
Alpfa Medical, Inc.
1880 EMBARCADERO ROAD, PALO ALTO, CA, 94303 · (669) 257-3263
Other Health Care · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$100.3M
Sold
$80.3M
% sold
80.1%
Investors
71
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | D ·current | 506(b) | $100.3M | $80.3M | 80.1% | 71 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Allan Zingeler — Executive Officer / Director, Palo Alto, CA
1 other raise
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
-
David Bonita — Director, Palo Alto, CA
6 other raises
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
- OrbiMed Partners II, L.P. $1.78B of —
- Thrombolex, Inc. $32.8M of $51.1M · 64.1%
- Treeline Biosciences, Inc. $200.1M of $250.0M · 80.0%
- Ikena Oncology, Inc. $0 of $75.0M · 0.0%
- Adela, Inc. $25.4M of $27.0M · 94.2%
-
Andrew ElBardissi — Director, Palo Alto, CA
1 other raise
- Adela, Inc. $25.4M of $27.0M · 94.2%
-
Michael Hurley — Director, Palo Alto, CA
2 other raises
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
- Lunair Medical, Inc. $7.5M of $12.5M · 60.0%
-
Michael Kramer — Director, Palo Alto, CA
8 other raises
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
- StrataBio Inc. $25K of $500K · 5.0%
- EnduraFAST Inc. $50K of $500K · 10.0%
- NB Capital Solutions III Cayman Feeder LP $145.0M of —
- NB Capital Solutions Fund III Delaware LP $1.3B of —
- NB Capital Solutions Fund III Cayman LP $1.12B of —
- Neuberger Talon LP $630.0M of —
- Neuberger Rise Aggregator LP $1.19B of —
-
Raju Viswanathan — Director, Palo Alto, CA
1 other raise
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
-
Michael Wiley — Executive Officer / Director, Palo Alto, CA
1 other raise
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
-
Rupa Patel — Executive Officer, Palo Alto, CA
1 other raise
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.